Founded in 2009, JYMed is a pharmaceutical enterprise in China that integrates R&D,manufacturing,commercialization,and custom development and manufacturing of peptide products. The company has approximately 570 employees, with a core management team composed of professionals with pharmaceutical expertise and over 20 years of experience in the peptide industry. JYMed operates one research center and two major production facilities, achieving multi-ton scale production capacity in peptides, positioning it as an industry leader.
JYMed offers a diverse portfolio of peptide APIs, including over 20 varieties such as Semaglutide, Tirzepatide, Liraglutide, Degarelix, and Oxytocin. Among these, five products, including Semaglutide and Tirzepatide, have successfully completed the FDA Drug Master File (DMF) registration.
JYMed offers high-quality cosmetic peptides, raw materials, and OEM formulation services from research grade to cGMP grade, all with stringent quality control. Our synthetic peptides, renowned for their safety and ease of modification, are essential ingredients in the cosmetic industry, delivering proven benefits for hair care, wound healing, anti-aging, anti-wrinkle, whitening, and eyelash growth.
JYMed has a comprehensive and efficient peptide industrialization system, offering clients full-spectrum services for peptide and peptide-analog products, including the research and production of therapeutic peptides, veterinary peptides, cosmetic peptides, and RNA, along with support for registration and regulatory compliance.
As a customer-oriented enterprise, JYMed has a comprehensive peptide industrialization system, with over 20 years experience in peptide R&D and state-of-the-art facilities. We provide a full range of high quality peptides based on the client's need:The quantity from mg to kg, the purity from crude to >99%, from non-GMP to GMP grade, from simple peptides to modified peptides, antigenic peptides development, confidential agreement is available.
Introduction of JYMed, a US FDA inspected peptide manufacturer. Featured products: cosmetic peptides, peptide APIs, custom peptides, such as, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, etc. To know more, please contact
Email: jymed@jymedtech.com
Recently, JYMed’s peptide production facility, Hubei Jianxiang Biopharmaceutical Co., Ltd., received two official documents issued by the Hubei Provincial Drug Administration: the “Drug GMP Compliance Inspection Result Notification” (No. E GMP 2024-258 and No. E GMP 2024-260) a...
From August 26 to August 30, 2024, JYMed’s peptide production facility, Hubei JX Bio-Pharmaceutical Co., Ltd., successfully passed an on-site inspection conducted by the U.S. Food and Drug Administration (FDA). The inspection covered key areas ...
01. Exhibition Overview On October 8th, the 2024 CPHI Worldwide Pharmaceutical Exhibition kicked off in Milan. As one of the most important annual events in the global pharmaceutical industry, it attracted participants from 166 countries and regions. With over...